Targeted therapies: PARP inhibitor olaparib is safe and effective in patients with BRCA1 and BRCA2 mutations

被引：20
|
作者：
Hutchinson L.
机构：
来源：
Nature Reviews Clinical Oncology | 2010年 / 7卷 / 10期
关键词：
D O I：
10.1038/nrclinonc.2010.143
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：549 / 549
相关论文
共 50 条
  • [1] Are prostate cancer patients with BRCA1 and BRCA2 mutations safe for active surveillance?
    Dall'era, Marc
    Evans, Christopher P.
    Pan, Chong-Xian
    Parikh, Mamta
    Lara, Primo
    McPherson, John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [2] BRCA1 and BRCA2 germline mutations in lymphoma patients
    Yossepowitch, O
    Olvera, N
    Satagopan, JM
    Huang, H
    Jhanwar, S
    Rapaport, B
    Boyd, J
    Offit, K
    [J]. LEUKEMIA & LYMPHOMA, 2003, 44 (01) : 127 - 131
  • [3] Breast surveillance of patients with BRCA1 and BRCA2 mutations
    Warner E.
    [J]. Current Breast Cancer Reports, 2013, 5 (3) : 255 - 261
  • [4] Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations
    Dedes, Konstantin J.
    Wilkerson, Paul M.
    Wetterskog, Daniel
    Weigelt, Britta
    Ashworth, Alan
    Reis-Filho, Jorge S.
    [J]. CELL CYCLE, 2011, 10 (08) : 1192 - 1199
  • [5] PHASE II STUDY OF THE ORAL PARP INHIBITOR OLAPARIB (AZD2281) VERSUS LIPOSOMAL DOXORUBICIN IN OVARIAN CANCER PATIENTS WITH BRCA1 AND/OR BRCA2 MUTATIONS
    Kaye, S.
    Kaufman, B.
    Lubinski, J.
    Matulonis, U.
    Gourley, C.
    Karlan, B.
    Taylor, D.
    Wickens, M.
    Carmichael, J.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 304 - 304
  • [6] Autoimmune response to PARP and BRCA1/BRCA2 in cancer
    Zhu, Qing
    Han, Su-Xia
    Zhou, Cong-Ya
    Cai, Meng-Jiao
    Dai, Li-Ping
    Zhang, Jian-Ying
    [J]. ONCOTARGET, 2015, 6 (13) : 11575 - 11584
  • [7] Screening for Genetic Mutations in BRCA1 and BRCA2
    Narod, Steven
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (12): : 1365 - 1365
  • [8] BRCA1 and BRCA2 mutations in patients with familial breast cancer
    Bolufer, P
    Munárriz, B
    Santaballa, A
    Velasco, E
    Lerma, E
    Barragán, E
    [J]. MEDICINA CLINICA, 2005, 124 (01): : 10 - 12
  • [9] Oophorectomy in women with BRCA1 or BRCA2 mutations
    Burki, Talha Khan
    [J]. LANCET ONCOLOGY, 2014, 15 (04): : E156 - E156
  • [10] BRCA1 and BRCA2 Mutations in Ovarian Cancer
    Buerkle, Bernd
    Tempfer, Clemens
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 359 - 359
12345